Evaluation and Comparison of Two Biomarkers (VOP and SCC) for the Prognosis of the Occurrence of Clinical Cardiovascular Events
NCT ID: NCT04300738
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
220 participants
INTERVENTIONAL
2020-05-15
2022-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Is there a superiority of PWV compared to SCC:
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective, Single-Center, Non-Randomized Study of the PhysioWave™ Cardiovascular Analyzer
NCT03126994
A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms
NCT06334913
Prediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population
NCT05951764
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population
NCT00741728
EVAluation of the Non Inferiority of Interpretability of Cardiokin Compared to Holter
NCT03932227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Pulse Wave Velocity is measured using a new device with half an hour learning curve, and you get a result within 2 minutes.
1. A non-invasive medical device vs invasive
2. A better benefit-risk ratio
3. A lower diagnostic cost both for equipment and for qualification for use and learning time
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing CT scann for CCS determination
CCS wit CT Scann measurement
Measurement with 2 devices
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CCS wit CT Scann measurement
Measurement with 2 devices
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Any Patient referred to the Bizet Clinic for a CT scan of the coronary arteries
3. Subject affiliated to a social security scheme or beneficiary of such a scheme
4. Lack of participation in another clinical study
Exclusion Criteria
2. Patient with obliterating arterial disease of the lower limbs
3. Patient with Sore fingers and hands
4. Patient with arrhythmia that does not allow measurement of VOP
5. Patient with limb amputation
6. Major subject protected by law, under curatorship or tutorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinique Bizet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benkessou
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01523-54
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.